Hjem › Juvenil myelomonocyt leukæmi
Juvenil myelomonocyt leukæmi kliniske forsøg rekrutterer i USA
9 studier for Juvenil myelomonocyt leukæmi rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Philadelphia, PA4 studier
- Minneapolis, MN4 studier
- Boston, MA3 studier
- Seattle, WA3 studier
- Memphis, TN3 studier
- Cincinnati, OH3 studier
- Atlanta, GA3 studier
- Chicago, IL3 studier
- Washington, DC3 studier
- Ann Arbor, MI3 studier
- San Francisco, CA3 studier
- New York City, NY3 studier
- Indianapolis, IN3 studier
Efter delstat
- Californien3 studier
- Colorado3 studier
- District of Columbia3 studier
- Florida3 studier
- Georgia3 studier
- Illinois3 studier
- Indiana3 studier
- Massachusetts3 studier
- Michigan3 studier
- Minnesota4 studier
- Missouri3 studier
- New York3 studier
- Ohio3 studier
- Pennsylvania4 studier
- Tennessee3 studier
- Texas3 studier
- Washington3 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
RekruttererFase 1/2
1 Month – 21 Years · Alle køn · Opdateret 4. sep. 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RekruttererFase 1
Alder 1 til 18 · Alle køn · Opdateret 25. aug. 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekruttererFase 1/2
Op til 22 år · Alle køn · Opdateret 25. aug. 2026 · NCT04726241CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Rekrutterer
Op til 25 år · Alle køn · Opdateret 8. jul. 2026 · NCT03810196Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RekruttererFase 2
Op til 60 år · Alle køn · Opdateret 25. jun. 2026 · NCT03314974A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
RekruttererFase 1
Alder 12 og opefter · Alle køn · Opdateret 17. jun. 2026 · NCT04024761Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
RekruttererFase 2
6 Months – 39 Years · Alle køn · Opdateret 4. jun. 2026 · NCT05800210HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
RekruttererFase 1
Op til 80 år · Alle køn · Opdateret 18. maj 2026 · NCT03326921MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
RekruttererFase 2
Op til 60 år · Alle køn · Opdateret 6. apr. 2026 · NCT05735717Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.